Jefferson Bridge Capital LLC Acquires New Stake in HCA Healthcare, Inc. $HCA

Jefferson Bridge Capital LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, Holdings Channel.com reports. The firm acquired 9,265 shares of the company’s stock, valued at approximately $4,325,000. HCA Healthcare makes up approximately 4.4% of Jefferson Bridge Capital LLC’s portfolio, making the stock its 5th biggest position.

A number of other hedge funds have also bought and sold shares of the business. Capital World Investors grew its stake in HCA Healthcare by 3.8% in the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock valued at $2,113,662,000 after buying an additional 179,443 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in HCA Healthcare by 1.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock valued at $880,199,000 after buying an additional 36,414 shares in the last quarter. Viking Global Investors LP grew its stake in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares in the last quarter. Legal & General Group Plc grew its position in shares of HCA Healthcare by 0.8% during the 3rd quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock valued at $479,267,000 after purchasing an additional 8,478 shares in the last quarter. Finally, Invesco Ltd. grew its position in shares of HCA Healthcare by 1.1% during the 3rd quarter. Invesco Ltd. now owns 1,100,929 shares of the company’s stock valued at $469,216,000 after purchasing an additional 11,829 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 15,214 shares of company stock valued at $7,797,595. Company insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on HCA. TD Cowen boosted their price target on shares of HCA Healthcare from $529.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, March 10th. Sanford C. Bernstein set a $541.00 price target on shares of HCA Healthcare in a research report on Monday, February 9th. Royal Bank Of Canada boosted their price target on shares of HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Weiss Ratings restated a “buy (b)” rating on shares of HCA Healthcare in a research report on Friday, March 27th. Finally, Oppenheimer lifted their price objective on shares of HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $537.73.

HCA Healthcare Stock Performance

NYSE HCA opened at $488.74 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $314.43 and a 52-week high of $556.52. The company has a market capitalization of $109.27 billion, a P/E ratio of 17.22, a P/E/G ratio of 1.45 and a beta of 1.36. The company has a fifty day moving average of $511.03 and a 200-day moving average of $480.20.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th were paid a $0.78 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Tuesday, March 17th. HCA Healthcare’s payout ratio is presently 10.99%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.